ALPHA-1 ANTITRYPSIN DOSING REGIMEN

The present invention is related to the use of alpha-1-antitrypsin as a therapeutic agent in patients that have suffered neural cell injury arising from traumatic or non-traumatic causes such as an ischemic stroke, cerebral hypoxia or spinal cord injuries. Alpha-1-antitrypsin administered in accorda...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CAMPRUBI GIMENEZ, Sandra, XIFRO COLLSAMATA, Francesc, Xavier, COSTA RIEROLA, Montserrat, HORRILLO SAURA, Raquel
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is related to the use of alpha-1-antitrypsin as a therapeutic agent in patients that have suffered neural cell injury arising from traumatic or non-traumatic causes such as an ischemic stroke, cerebral hypoxia or spinal cord injuries. Alpha-1-antitrypsin administered in accordance with the treatment regimen of the present invention may also find utility in the treatment of neuropathic pain and the promotion of spinal cord revascularisation following injury thereto. Compositions comprising alpha-1 antitrypsin may be administered parenterally or by inhalation to the patients as part of an innovative dosing regimen.